CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-14 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +500 | $3.45 | $2K | 193,072,194 |
| 2021-09-14 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +5,825 | $3.45 | $20K | 193,078,019 |
| 2021-09-14 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +21,905 | $3.45 | $76K | 193,099,924 |
| 2021-09-14 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +10,100 | $3.46 | $35K | 193,110,024 |
| 2021-09-14 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +400 | $3.47 | $1K | 193,110,424 |
| 2021-09-14 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +44,085 | $3.47 | $153K | 193,154,509 |
| 2021-09-14 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +400 | $3.48 | $1K | 193,154,909 |
| 2021-09-14 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +16,785 | $3.48 | $58K | 193,171,694 |
| 2021-08-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +4,518 | $3.68 | $17K | 192,976,212 |
| 2021-08-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +13,682 | $3.68 | $50K | 192,989,894 |
| 2021-08-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +5,108 | $3.69 | $19K | 192,995,002 |
| 2021-08-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +2,292 | $3.69 | $8K | 192,997,294 |
| 2021-08-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +53,873 | $3.69 | $199K | 193,051,167 |
| 2021-08-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +500 | $3.70 | $2K | 193,051,667 |
| 2021-08-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +17,988 | $3.70 | $67K | 193,069,655 |
| 2021-08-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +700 | $3.71 | $3K | 193,070,355 |
| 2021-08-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +1,339 | $3.71 | $5K | 193,071,694 |
| 2021-08-09 | HSIAO JANE PH D Vice Chairman & CTO | Purchase | +10 | $3.73 | $37 | 27,599,870 |
| 2021-06-24 | Yu Alice Lin-Tsing Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2021-06-24 | PFENNIGER RICHARD C JR Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 |
Page 28 of 33 · 653 trades